- Merck (MRK) declared a $0.85 quarterly cash dividend for Q4 2026; record date Sept 15, 2026, payment date Oct 7, 2026.
- U.S. lawmakers asked Merck (MRK) for details on data protection and oversight of China-based clinical trials, citing biotech security concerns at Xinjiang sites and military-linked hospitals.
- Merck (MRK) will help manufacture an experimental Bundibugyo Ebola vaccine using its rVSV platform, supplying technical support and doses for early-stage trials by year-end; CEPI funds up to $8.5M.
- Merck (MRK) agreed to a $50 million settlement over Gardasil lawsuits. Company defended Gardasil’s safety and efficacy. Spokesperson said neither Robert F. Kennedy Jr. nor his son will get fees.
TradingView
Key facts: Merck & Co., Inc. $0.85 Q4 Dividend; China Trial Probe; Ebola Vaccine Aid
- Sources
- TradingView
- Markets
- Stocks
- Active symbols
- NYSE:MRK
- Language
- English (India)
Merck (MRK) declared a $0.85 quarterly cash dividend for Q4 2026; record date Sept 15, 2026, payment date Oct 7, 2026.U.S. lawmakers asked Merck (MRK) for details on data protectio